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Signaling pathways implicated in the stimulation of beta-cell
proliferation by extracellular matrix
Abstract
Laminin-5-rich extracellular matrix derived from 804G cells (804G-ECM) induces spreading, improves
glucose-stimulated insulin secretion, and increases survival and proliferation of rat pancreatic beta-cells.
The aim of the study was to determine growth signaling pathways activated by ECM with a particular
focus on Ca(2+)-dependent transcription factors. 804G-ECM increased rat beta-cell proliferation, and
this stimulation was glucose and Ca(2+) dependent. NF-kappaB nuclear translocation as well as
IkappaBalpha gene expression were also Ca(2+) dependent. Inhibition of NF-kappaB almost completely
blocked 804G-ECM-stimulated beta-cell proliferation as did the soluble IL-1 receptor antagonist
IL-1Ra. 804G-ECM-induced proliferation was also blocked by cyclosporin A and the VIVIT peptide,
suggesting involvement of nuclear factor of activated T cells (NFAT)/calcineurin. Use of selective
inhibitors further implicated other pathways in this process. Inhibition of phosphatidylinositol 3-kinase
and protein kinase A both prevented beta-cell replication stimulated by 804G-ECM. Conversely,
inhibition of MAPK, c-Jun N-terminal kinase, p38, and glycogen synthase kinase-3beta increased
beta-cell proliferation on 804G-ECM. Our results suggest that Ca(2+) entry, which is necessary for
increased beta-cell proliferation on 804G-ECM, is also involved in 804G-ECM-induced NF-kappaB
activity. It is proposed that increased cytosolic Ca(2+) leads to activation of the transcription factors
NFAT and NF-kappaB that in turn increase beta-cell proliferation. Activation of phosphatidylinositol
3-kinase by 804G-ECM also increases proliferation possibly by synergistic coactivation of NFAT via
inhibition of glycogen synthase kinase-3beta, whereas IL-1beta may amplify the process by
feed-forward activation of NF-kappaB. Conversely, inhibition of the MAPK pathway increased beta-cell
proliferation, indicating a counterregulatory restraining role for this signaling pathway.
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Laminin-5-rich extracellular matrix derived from 804G cells (804G-ECM) induces spreading, im-
proves glucose-stimulated insulin secretion, and increases survival and proliferation of rat pan-
creatic-cells. The aimof the studywas to determine growth signaling pathways activated by ECM
with a particular focus on Ca2-dependent transcription factors. 804G-ECM increased rat -cell
proliferation, and this stimulation was glucose and Ca2 dependent. NF-B nuclear translocation
as well as IB gene expression were also Ca2 dependent. Inhibition of NF-B almost completely
blocked 804G-ECM-stimulated -cell proliferation as did the soluble IL-1 receptor antagonist
IL-1Ra. 804G-ECM-induced proliferation was also blocked by cyclosporin A and the VIVIT peptide,
suggesting involvement of nuclear factor of activated T cells (NFAT)/calcineurin. Use of selective
inhibitors further implicated other pathways in this process. Inhibition of phosphatidylinositol
3-kinase and protein kinase A both prevented -cell replication stimulated by 804G-ECM. Con-
versely, inhibition of MAPK, c-Jun N-terminal kinase, p38, and glycogen synthase kinase-3 in-
creased -cell proliferation on 804G-ECM. Our results suggest that Ca2 entry, which is necessary
for increased -cell proliferation on 804G-ECM, is also involved in 804G-ECM-induced NF-B ac-
tivity. It is proposed that increased cytosolic Ca2 leads to activation of the transcription factors
NFAT and NF-B that in turn increase -cell proliferation. Activation of phosphatidylinositol
3-kinase by 804G-ECM also increases proliferation possibly by synergistic coactivation of NFAT via
inhibition of glycogen synthase kinase-3, whereas IL-1may amplify the process by feed-forward
activation of NF-B. Conversely, inhibition of the MAPK pathway increased -cell prolifera-
tion, indicating a counterregulatory restraining role for this signaling pathway. (Molecular
Endocrinology 23: 1264–1271, 2009)
The extracellular matrix (ECM) is a complex structural entitysurrounding cells within mammalian tissues that is able to
regulate many essential cellular functions, including gene ex-
pression (1, 2), survival, development (3, 4), migration, prolif-
eration, shape, and secretion (5).
Our group has reported that the laminin-5-rich ECM se-
creted by 804G cells (804G-ECM) has a beneficial effect on rat
pancreatic -cell survival and proliferation and that it activates
intracellular signaling pathways involving the signaling proteins
focal adhesion kinase (FAK), Akt/protein kinase B (PKB), and
ERK (6, 7). Furthermore, it was found that plating rat -cells on
804G-ECM induces transient nuclear translocation of nuclear
factor (NF)-B and its transcriptional activity, which is followed
by overexpression of IB and NF-B mRNAs (8). 804G-ECM
also triggers the low-grade expression of cytokines, notably IL-1,
which is released and acts in an autocrine fashion via its receptor
IL-1R to positively reinforce the activation of NF-B and possibly
its own expression in -cells plated on 804G-ECM (9, 10).
It is well established that in -cells glucose metabolism
induces an increase in intracellular Ca2 and we have shown
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that such an increase is also required for spreading of rat islet
-cells on extracellular matrix (11, 12). Furthermore, Ca2 is
an essential regulator of the cell cycle and the amplitude and
duration of the Ca2 response control gene expression in
various cell types (12).
Recently, nuclear factor of activated T cells (NFAT) had been
shown to regulate pancreatic -cell growth and function (13). A
sustained increase in cytosolic Ca2 is necessary to dephos-
phorylate NFAT by calcineurin, a Ca2/calmodulin-dependent
phosphatase, and induce its translocation into the nucleus (14).
Glycogen synthase kinase (GSK)-3 is a negative regulator of
this signaling pathway because it phosphorylates NFAT and
induces its export from the nucleus. Inactivation of GSK3 by
phosphorylation on Ser9 by Akt/PKB is necessary to assure
NFAT-dependent transcription (14).
We have now investigated the role of Ca2-dependent sig-
naling pathways in the stimulation of -cell growth by ECM,
with a particular focus on NF-B and NFAT.
Results
ECM increases expression of cell cycle proteins
In confirmation of previous findings, after 2 d culture, 804G-
ECM significantly increased proliferation of rat -cells vs. poly-L-
lysine (PLL) (control) using standard culture conditions [DMEM,
10% fetal calf serum (FCS), 11.2 mM glucose]: 1.8 0.4 vs. 4.6
0.5%of BrdU-positive -cells on PLL vs. 804G-ECM, respectively
(P 0.006). 804G-ECM also significantly modified expression of
proteins of the cell cycle. Indeed, expression of proliferating cell
nuclear antigen (PCNA) and cyclin D1 were significantly in-
creased in cells plated on 804G-ECM compared with cells on
PLL (Fig. 1, A and B), whereas expression of cyclin-depen-
dent kinase 4 (CDK4) and cyclin D2 was similar
between cells attached on 804G-ECM or on PLL
(Fig. 1, B and C).
ECM increased rat -cell proliferation is
glucose and calcium dependent
Spreading of -cells on 804G-ECM is glucose
dependent (11). We have now investigated -cell
proliferation at low (2.8 mM) or high (11.2 mM,
standard) glucose for 24 h. At 2.8 mM glucose, rat
-cell proliferation was similar for cells on PLL and
804G-ECM (Fig. 2A). Increasing the glucose con-
centration (11.2 mM) significantly enhanced -cell
proliferation both on PLL and on 804G-ECMwhen
compared with cells exposed to 2.8 mM glucose.
However, a 6.8-fold increase in -cell proliferation
was observed with glucose on 804G-ECM against a
3.3-fold increase on PLL (Fig. 2A), indicating a syn-
ergistic or permissive effect of glucose on the in-
creased proliferation of -cells on ECM. As ex-
pected, the accumulation of insulin released to the
medium during the 24-h culture period was signifi-
cantly increased when cells were cultured with 11.2
mM glucose when compared with 2.8 mM (Fig. 2B).
However, no significant difference was observed between PLL
and 804G-ECM even at high glucose concentration. These re-
sults suggest that the beneficial effect of matrix on -cell prolif-
eration seen at 11.2 mM glucose is not simply due to an increase
in insulin release of cells attached on 804G-ECM.
Glucose metabolism results in the production of ATP, with
subsequent closure of KATP channels, membrane depolariza-
tion, and opening of voltage-operated Ca2 channels. To inves-
tigate whether the KATP channel influences glucose-induced
-cell proliferation, we examined the effect of the sulfonamide
diazoxide on -cell proliferation. Diazoxide opens KATP chan-
nels, thereby preventing depolarization and Ca2 entry. The
KATP channel opener diazoxide decreased proliferation of
-cells attached to 804G matrix and abolished the difference
between cells on PLL and 804G (Fig. 2C). To further address the
role of calcium influx through the L-type voltage-gated Ca2
channels in -cell proliferation, these channels were blocked
with the specific agent SR-7037. As shown in Fig. 2C, 1 M
SR-7037 decreased 804G-ECM-induced proliferation.
Activation of NF-B by 804G-ECM is calcium dependent
and is involved in rat -cell proliferation
As previously shown (8), 804G-ECM increases significantly
NF-B nuclear translocation as well as IB gene expression, a
target of NF-B. Because Ca2 signaling is known to be in-
volved in activation of this pathway, we examined the impact of
Ca2 entry blockers on NF-B activation. Treatment of -cells
with the KATP channel opener diazoxide or the L-type Ca
2
channel blocker SR-7037 prevented ECM-induced NF-B nu-
clear translocation (Fig. 3A). Furthermore, ECM-induced IB
gene expression was also significantly reduced in the presence of
the two inhibitors of calcium influx (Fig. 3B). The inhibitor of
NF-B activation Bay 11-7082 (5 M) blocked almost com-
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FIG. 1. Levels of PCNA and cyclin D1 protein are increased in -cells cultured 48 h on 804G-
ECM vs. PLL. A, Upper panel, representative Western blot for PCNA and actin (confirming
equivalent protein loading); lower panel, quantification of band intensities (PCNA/actin); n  3.
*, P  0.03 vs. PLL. B, Upper panel, representative Western blot for cyclin D1, CDK4, and actin
(confirming equivalent protein loading); lower panel, quantification of band intensities (cyclin
D1/actin and CDK4/actin); n  4. *, P  0.04 vs. PLL. C, Upper panel, representative Western
blot for cyclin D2 and actin (confirming equivalent protein loading); lower panel, quantification
of band intensities (cyclin D2/actin); n  3.
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pletely -cell proliferation on 804G-ECM but also on PLL (Fig.
3C). Because IL-1 is a known target of NF-B that is secreted
from rat -cells on ECMand appears to act on them in a positive
feedback loop in this particular setting (9), we blocked the IL-1R
with IL-1R antagonist (IL-1Ra) (2 g/ml), and this indeed re-
sulted in a significant decrease in -cell proliferation on 804G-
ECM (Fig. 3D).
Analysis of the calcium signaling pathways involved in
ECM-induced -cell proliferation
NFAT signaling has been shown to regulate pancreatic -cell
growth and function (13). To determine the importance of the
NFAT pathway on ECM-induced proliferation, we tested the
effect of two agents known to act on this pathway (Fig. 4).
Cyclosporin A (5 M), an inhibitor of calcineurin, prevented
ECM-induced -cell proliferation without significantly affect-
ing proliferation of cells plated on PLL (Fig. 4A). Furthermore,
the direct inhibition of NFAT by VIVIT peptide partially inhib-
ited 804G-ECM-induced -cell proliferation (Fig. 4B), again
with no impact on proliferation on PLL.
Involvement of phosphatidylinositol 3-kinase (PI3K) and
MAPK signaling pathways in 804G-ECM-induced
-cell proliferation
NF-B and NFAT are also modulated by non-calcium-de-
pendent pathways, including the MAPK and PI3K pathways.
Furthermore, it was previously shown that 804G-ECM acti-
vates intracellular pathways in -cells involving the signaling
proteins Akt/PKB and ERK (8). Therefore, -cells were cultured
48 h on PLL or on 804G-ECM in the presence of a PI3K inhib-
itor, LY294002, or aMAPK inhibitor, PD98059, during the last
24 h. Treatment of -cells with LY294002 (50 M) completed
prevented increased proliferation on 804G-ECM (Fig. 5A)
with no significant decrease on PLL. By contrast, addition of
PD98059 for the last 24 h of culture had no effect on prolifer-
ation (Fig. 5B). To investigate the effects of inhibiting MAPK
signaling for a longer period of time, various inhibitors were
included in the culture medium throughout the 48-h culture
period. Interestingly, with this longer period of inhibition of
MAPK kinase (MEK)/ERK by PD98059, the percentage of bro-
modeoxyuridine (BrdU)-positive -cells was significantly in-
creased on 804G-ECM when compared with control (Fig. 5C).
However, no effect of this MAPK inhibitor was observed on
cells plated on PLL (Fig. 5C). Similar results were obtainedwhen
cells were incubated with SP600125 (10 M), a c-Jun N-termi-
nal kinase (JNK) inhibitor (Fig. 5D) and with SB20358 (10 M),
a p38 MAPK inhibitor (Fig. 5E). However, with this last inhib-
itor, the increase in proliferation was very high (4.3-fold vs.
control on ECM) and was also observed on PLL (7-fold vs.
control on PLL). These latter data suggest that when p38MAPK
is activated, it serves as a brake for -cell proliferation and that
this process is independent of the ECM effect. However, we
observed no differences in phospho-p38 and phospho-JNK be-
tween cells plated on PLL or on 804G-ECM for 48 h (data not
shown).
Finally, we analyzed the effect of 804G-ECM on the PI3K/
Akt signaling cascade. A 30-min attachment of cells on 804G-
ECM-induced phosphorylation on Ser9 of GSK3, a target of
Akt (Fig. 6A), with no effect on the amount of total GSK3. We
also tested the effect of 6-bromoindirubin-3-oxime (BIO), a
GSK3 inhibitor on -cell proliferation. Treatment of cells with
BIO (1 M) for 48 h significantly increased proliferation of cells
plated on 804G-ECM but not on PLL (Fig. 6B). PKA is known
to phosphorylate and thereby inhibit GSK3. Inhibition of PKA
should thus activate GSK3 and induce the opposite effects seen
with its inhibition by BIO. Indeed, when PKA was inhibited by
48 h treatment with 10 M H89, -cell proliferation on 804G-
ECM was significantly decreased (Fig. 6C).
Discussion
ECM has been reported to enhance cell attachment and prolif-
eration as well as to induce differentiation in vitro (15). Re-
cently, we demonstrated that primary rat -cell proliferation is
significantly increased by ECM (7). Here we show that ECM
increases expression of two cell cycle proteins, PCNA and cyclin
D1, in -cells. PCNA is a nuclear nonhistone antigen that ap-
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FIG. 2. Increased proliferation of rat -cells on 804G-ECM is glucose and
calcium dependent. A, Rat -cells were attached either on PLL or 804G-ECM and
cultured in DMEM, 10% FCS with 2.8 or 11.2 mM glucose as indicated. After
24 h culture, cells were incubated for another 24 h in the presence of BrdU (10
M). Immunofluorescence for BrdU (proliferation) and insulin (-cells) was
performed and the number of BrdU plus insulin double-positive -cells expressed
as a percentage of the total number of (insulin-positive) -cells and then
normalized to 804G-ECM 11.2 mM (absolute value, 3.63  0.23). *, P  0.01 vs.
respective 2.8 mM glucose control; **, P  0.01 vs. PLL at 11.2 mM glucose. B,
Insulin secreted in the medium during 24 h culture was measured by RIA. *, P 
0.01 vs. respective 2.8 mM glucose control. C, Cells were cultured under
standard conditions (11.2 mM glucose) as described for A but with addition of
diazoxide (200 M) or SR-7037 (1 M), as indicated; n  3–5. *, P  0.05 vs. PLL
control; **, P  0.05 vs. 804G-ECM control (804G-ECM control absolute value,
2.740.63).
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pears in the nucleus during late G1 phase, increases during S
phase, and decreases during G2 and M phases (16). PCNA ex-
pression is thus an indicator for cell proliferation and has been
used to determine-cell mass expansion in rats (17). Three types
of cyclin D, namely D1, D2, and D3, play an essential role in
promoting cell cycle progression fromG1 to S phase (18). Cyclin
D1 and D2 are expressed in -cells and are important regulators
of -cell proliferation, whereas cyclin D3 is expressed at low
levels (19–22). In our study, we show that ECM increases ex-
pression of cyclin D1 but not of cyclin D2. This could be ex-
plained by the fact that expression of the D-type cyclins is de-
pendent on mitogenic stimulation. Indeed, cyclin D1 but not
cyclin D2 expression is induced by glucagon-like peptide 1
(GLP-1) (23). The signaling pathway regulating cyclin D1 ex-
pression in -cells is unknown even if overexpression of cyclin
D1 in cultured islets increases -cell proliferation (24).
Our results show that the ability of ECM to increase rat
-cell proliferation is glucose dependent as reported previously
for cell spreading (11). It has long been known that glucose is a
potent -cell mitogen (25). In rats, glucose infusion results in an
approximately 50% increase in both -cell proliferation and
mass (26–28). In our study, we confirm that glucose signifi-
cantly increases the proliferation of rat -cells in vitro and fur-
ther show that ECMcan stimulate proliferation only at 11.2mM
glucose and not at 2.8 mM. An inherent complication in studies
of glucose effects on -cells is the difficulty in sep-
arating the effect of glucose from those of insulin. A
recent study has thus demonstrated that insulin se-
creted by -cells in response to elevated glucose
exerts autocrine effects to stimulate proliferation
(29). However, the addition of exogenous insulin
(at a concentration similar to that found in sur-
rounding cells at high glucose) to -cells cultured at
2.8 mM glucose increased cell proliferation but to a
lower extent than that observed with 11.2 mM glu-
cose (data not shown). There was, however, no
impact of ECM on the total amount of insulin ac-
cumulating in the medium during the test culture
period. These results suggest that glucose itself may
be considered as a mitogen in our study, but we do
not exclude a synergistic contribution from insulin.
It was not the purpose of the present study to elab-
orate further on this.
Glucose metabolism induces an increase in in-
tracellular Ca2, and we have shown that in-
creased intracellular calcium is required for spread-
ing of rat islet -cells on extracellular matrix (11).
Here we show that 804G-ECM-induced NF-B ac-
tivation is Ca2 dependent. Activation of NF-B
by depolarization and Ca2 influx has been reported
in MIN6 insulinoma cells (30). 804G-ECM-in-
duced rat -cell proliferation was prevented by
inhibitionofCa2 influx. Furthermore, calcineurin, a
ubiquitous calcium-activated serine phosphatase,
seems to be implicated because its inhibition by
cyclosporin A decreased -cell proliferation in-
duced by 804G-ECM. Recently, calcineurin/NFAT
signaling has been shown to regulate pancreatic -cell growth
and function (13, 31). Calcineurin is also known to activate the
canonical NF-B/NFAT pathway induced by inflammation in
astrocytes and lymphocytes (32, 33). We further show that in-
hibition of NF-B with Bay 11-7082 significantly decreased
-cell proliferation. The association between normal growth
and NF-B activation has been noted in many cells and tissues
(34, 35). Further experiments in many cell types now indicate
that NF-kB acts through increasing the abundance of cyclin D1
(34). Therefore, in our condition, the increase in cyclin D1 ex-
pression could similarly be due to 804G-ECM-induced NF-B
activation. IL-1, which is secreted by -cells plated on this
particular ECM, can activate NF-B (9). It is important to stress
that in this particular context, the modest and relatively short-
lived activation of NF-B induced in rat -cells by ECM is
thought to be beneficial (8, 9). Nowwe show that this activation
of NF-B by IL-1may contribute toward increased -cell pro-
liferation on ECM because treatment with IL-1Ra reduced sig-
nificantly the ECMeffect. This correlates with a finding that low
concentrations of IL-1 increase human islet cell replication,
whereas high levels induce apoptosis in the same cells (36).
The response of cells to ECM attachment is mediated pri-
marily by the integrin family of adhesion receptors. It has been
shown that 804G-ECM effects on pancreatic -cells (spreading,
glucose-stimulated insulin secretion, and survival) are mediated
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FIG. 3. Calcium-dependent NF-B activity is involved in rat -cell proliferation. A, Rat -cells
were fixed after 1 h exposure to PLL or 804G-ECM in presence or not of diazoxide (200 M) or
SR-7037 (1 M), and NF-B was detected by immunofluorescence. The number of cells with
nuclear NF-B localization was quantified as a percentage of total. *, P  0.05 vs. PLL; **, P 
0.05 relative to control 804G-ECM (n  3) with a minimum of 100 -cells examined for each
condition in each experiment. B, Cells were cultured on PLL or on 804G-ECM-coated dishes in the
presence or not of inhibitors for 24 h; mRNA was extracted, and quantitative real-time RT-PCR
was performed to quantify levels of IB mRNA vs. L3 mRNA (internal control). *, P  0.05 vs.
PLL; **, P  0.05 vs. 804G-ECM (n  6). C and D, Rat -cells were attached either on PLL or on
804G-ECM in the presence or not of inhibitors of NF-B (C, Bay11-7082 5 M) or IL-1 (D, IL1-Ra
2 g/ml). After an initial period of 24 h, cells were cultured with BrdU (10 M) for another 24 h in
continued presence of the inhibitors. -Cell replication was determined as described in Fig. 2
(804G-ECM control absolute value, 2.87  0.5 for C and 3.2  0.8 for D); n  3–4. *, P  0.05
vs. PLL control; **, P  0.05 vs. 804G-ECM control.
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by the engagement of 1 integrins to laminin-5 (6, 37), which
leads to focal adhesion kinase (FAK) phosphorylation and
downstream activation of the PI3K/Akt pathway. Therefore,
integrin signaling may induce the same signaling transduction
cascades as growth factors and consequently may have compa-
rable effects on cell cycle progression. Results of the present
study provide evidence that ECM induces -cell proliferation by
activating the PI3K/Akt pathway, which could lead to NFAT
nuclear translocation. We have previously demonstrated that
ECM induces phosphorylation of Akt (6). Here we demonstrate
that ECM induces also phosphorylation of its downstream tar-
get GSK3 (thereby inhibiting its activity and so decreasing
phosphorylation and export of NFAT from the nucleus). More-
over, we show that inhibition of GSK3 increases -cell prolif-
eration, whereas PKA inhibition, which induces activation of
GSK3, inhibits -cell replication. Our results are in accordance
with recent reports showing that overexpression of GSK3 re-
duced mouse -cell mass and proliferation (38, 39). Interest-
ingly, activation of GSK3 (by inhibiting Akt or PKA) and
therefore export of NFAT from the nucleus has a more pro-
nounced impact on -cell proliferation than direct inhibition of
NFAT translocation to the nucleus (by inhibiting calcineurin or
with VIVIT peptide). This may suggest that GSK3 regulates
other signaling molecules than NFAT implicated in -cell pro-
liferation. Indeed, GSK3 regulates cell growth by inhibition
and/or degradation of a large number of signaling molecules
implicated in gene transcription, cell metabolism, and protein
synthesis (40). One of them could be NF-B, because it has been
shown that GSK3 negatively regulates NF-B (41).
The increase of ECM-induced -cell proliferation by (48 h)
inhibition of the MAPK pathway was not expected because it
has been found to be involved in crucial functions implicated in
proliferation. Furthermore, ERK has been demonstrated to be
essential in triggering proliferation in response to growth factors
(42, 43). However, it is known that depending on the cell type
and the stimuli, these enzymes can be either inhibited or acti-
vated by the same secondary messenger. Therefore, MAPK sig-
naling proteins are dynamic and may play different roles at
different times (44). Indeed, in vascular smoothmuscle cells, cell
proliferation in three-dimensional matrices was inversely corre-
lated to ERK activation (45). Inhibition of p38MAPK increased
-cell proliferation regardless of the substrate used. It has been
already reported that p38 appears to negatively influence cell
cycle progression in many cells (46, 47). A conditionally acti-
vated form ofMEKkinase 3 arrests fibroblast cell cycle, and this
effect could be mediated via p38MAPK, a downstream effector
of MEK kinase 3 (48). Interestingly, p38 MAPK inhibition has
been shown to enable proliferation of adult mammalian cardi-
omyocytes (49), cells that were considered terminally differen-
tiated and incapable of proliferation, like-cells a few years ago.
In summary, our work describes possible mechanisms for
regulation of -cell proliferation in response to ECM. Increased
levels of intracellular Ca2 are necessary for 804G-ECM in-
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creased -cell proliferation, with involvement of downstream
activation of NF-B. IL-1 may amplify this process by feed-
forward activation of NF-B. Calcium entry can also activate
the calcineurin/NFAT signaling to induce -cell proliferation.
Furthermore, activation of the PI3K cascade by integrin-ECM
interactionmay promote -cell proliferation through phosphor-
ylation and inhibition of GSK3ß. This study shows that -cell
proliferation can be enhanced by ECM via activation or inhibi-
tion of multiple signaling pathways. Due to the difficulty to
increase human -cell proliferation in vitro (7), it will be critical
to learn in future studies if pharmacologic inhibition or activa-
tion of these specific pathways can be used to induce human
-cell regeneration.
Materials and Methods
Materials
Bay 11-7082 was from BioMol Research Laboratories (Hamburg,
Germany) and IL-1Ra (Kineret) from Amgen (Europe B.V., Breda, The
Netherlands). PD98059, LY294002, diazoxide, SR-7037, cyclosporin
A, VIVIT peptide, SB20358, SP600125, and H89 were purchased from
Calbiochem (Darmstadt, Germany). BIO was the kind gift from Rock-
efeller University (New York, NY). Primary antibodies for immunoflu-
orescence were polyclonal anti-p65 subunit of NF-B (C-20) from Santa
Cruz Biotechnology (Santa Cruz, CA) and guinea pig antiinsulin serum
(Domenico Bosco; University of Geneva, Geneva, Switzerland). Primary
antibodies for Western blot were monoclonal anti-PCNA (Signet,
Alexis Corp., Lausen, Switzerland); polyclonal anti-GSK3, and anti-
phospho-GSK3 (Ser9) (Cell Signaling Technology-Bioconcept,
Allschwil, Switzerland); monoclonal anti-cyclin D1, monoclonal anti-
cyclin D2, and polyclonal anti-CDK4 (Santa Cruz Biotechnology),
monoclonal anti-actin (Sigma Chemical Co., St. Louis, MO). Secondary
antibodies were Alexa fluor 488-conjugated anti-guinea pig from Mo-
lecular Probes (Eugene, OR) and fluorescein isothiocyanate-conjugated
goat antirabbit (Sigma) for immunofluorescence and antimouse horse-
radish peroxidase and antirabbit horseradish peroxidase (Amersham
Pharmacia Biotech, Du¨bendorf, Switzerland) for Western blot. Hoechst
33342 was from Sigma Fluka (Buchs, Switzerland).
Islet isolation and -cell purification
All experiments were performed on primary pancreatic -cells
sorted from adult rat islet cells by autofluorescence-activated flow cy-
tometry. Islets of Langerhans were isolated by collagenase digestion of
pancreas from male Wistar rats (weighing 150–
200 g), followed by Ficoll purification. Islets were
trypsinized and -cells purified using a fluores-
cence-activated cell sorter (FACStar-Plus; Becton
Dickinson, Sunnyvale, CA) as described (37, 50),
by autofluorescence to yield a population of more
than 95% -cells.
804G-ECM matrix preparation
The 804G cells were the kind gift of Desmos
(San Diego, CA). ECM from medium conditioned
by 804G cells was prepared and used as described
previously (51). They were grown in DMEM
(GIBCO, Invitrogen, Basel, Switzerland), contain-
ing 10% FCS and 5.6 mM glucose. At confluence,
cells were rinsed and maintained for another 3 d in
the same medium in the absence of FCS. Condi-
tioned medium (referred to hereafter as 804G-
ECM) was collected, centrifuged at 120  g for
10 min to remove any detached cells and debris,
filtered through a 0.22-m Millipore filter, and frozen at 20 C for
later use.
Coating of plastic dishes with poly-L-lysine
and 804G-ECM
Aliquots (60 l) of PLL (100 g/ml) or of 804G-ECM were layered
at the center of 35-mm culture petri dishes (adherent dishes for mam-
malian cell culture). Dishes were kept in a damp box at 37 C for 18–20
h before being rinsed three times with sterile H2O and air dried. Dishes
coated with PLL were used as controls.
Cell culture
Sorted -cells were washed twice in 10–15 ml sterile DMEM
(GIBCO, Invitrogen) containing 10% FCS, 11.2 mM glucose, and 110
g/ml sodium pyruvate and supplementedwith 110U/ml penicillin, 110
g/ml streptomycin, and 50 g/ml gentamycin, followed by centrifuga-
tion for 10 min at 130  g. Aliquots of 3  105 cells were seeded in
nonadherent 100-mm-diameter petri dishes containing 9 ml medium.
Cells were then incubated for 20 h at 37 C to allow full recovery of any
cell surface molecules that may have been lost or damaged during islet
isolation or cell purification. After recovery, cells were resuspended at a
density of 4 105 cells/ml in control DMEM supplemented or not with
inhibitors at the indicated concentration. Aliquots (50 l) of this sus-
pension were plated as droplets at the center of petri dishes coated with
804G-ECM or PLL and were incubated at 37 C. One day later, cells
were incubated with 10MBrdU for 24 h under control conditions or in
the continued presence of the inhibitor. The inhibitors were dissolved in
dimethylsulfoxide, which was also added to control cultured cells at the
same concentration. In addition, medium (50 l) was collected and
centrifuged to remove any detached cells and debris and stored at 20
C for subsequent insulin measurement.
Detection of proliferation by immunofluorescence
Cell replicationwas determined by BrdU incorporation and the iden-
tity of -cells confirmed by insulin immunofluorescence. -Cells incu-
bated with BrdU were fixed (1% paraformaldehyde, 1 h room temper-
ature) and DNA denatured (1.5 M HCl, 1 h room temperature). After
permeabilization (0.5% Triton X-100, 4 min), proliferation was esti-
mated using an immunohistochemical assay kit as described by the
manufacturer (BrdU labeling and detection kit; Roche, Bale, Switzer-
land). Cells were also costained for insulin (guinea pig anti-insulin serum
1:500). After extensive washing, cells were incubated with Alexa fluor
488-conjugated antiguinea pig Ig. Nuclei were stained with 10 g/ml
Hoechst 33342. The percentage of cells double positive for insulin and
BrdU per total number of insulin single-positive cells was calculated.
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FIG. 6. Involvement of PI3K signaling in 804G-ECM-induced -cell proliferation. A, Lysates of rat -cells
attached on PLL or 804G matrix for 30 min were immunoblotted with anti-phospho-GSK3 (Ser9) and
anti-actin antibodies. Then, the immunoblot was stripped and reprobed for total GSK3 protein.
Representative results are shown from one experiment. B, Rat -cells were attached either on PLL or on
804G-ECM in the presence or not of inhibitors of GSK3 (1 M BIO) (B) or of PKA (10 M H89) (C). After
an initial period of 24 h, cells were cultured with BrdU (10 M) for another 24 h. -Cell replication was
determined as described in Fig. 2 (804G-ECM control absolute value, 3.32  0.34 for B and 2.26  0.38
for C); n 3–5. *, P  0.05 vs. PLL control; **, P  0.05 vs. 804G-ECM control.
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Insulin measurement
Insulin release during the 24 h of culture was measured by RIA with
rat insulin as the standard.
NF-B activation
The cellular localization of NF-B in various conditions was ana-
lyzed by immunofluorescence. Cells were fixed with 4% paraformalde-
hyde (20 min, room temperature) and permeabilized with 0.5% Triton
X-100 (5 min, room temperature), and immunofluorescence for NF-B
was performed. The percentage of cells with dominant nuclear NF-B
staining was determined (five different fields were examined for each
condition).
Quantitative real-time PCR
RNA was isolated using RNeasy mini kit (QIAGEN, Hombrech-
tikon, Switzerland). cDNAwas synthesized with Superscript II (Invitro-
gen), using 1 g total RNA in a 20-l reaction volume. The double-
stranded DNA-specific dye SYBR Green I (Eurogentech, Seraing,
Belgium) and fluorescein (Bio-Rad, Bâle, Switzerland) were incorpo-
rated into the PCR buffer (qPCR core kit; Eurogentech) to allow for
quantitative detection of the PCR product. The results were analyzed
using the iCycler iQ System (Bio-Rad). The housekeeping gene L3 was
used as an internal control. The primers used were as follows: IB
forward 5-TGC TGA GGC ACT TCT GAA AGC-3 and IB reverse
5-TCC TCG AAA GTC TCG GAG GTC-3.
Western blot analysis
To analyze phospho-GSK3, total GSK3, PCNA, cyclin D1, and
CDK4 protein expression, attached cells were washed with ice-cold PBS
supplemented with 1 mM sodium vanadate and protease inhibitors and
lysed in sample buffer 1 [62 mM Tris-HCl (pH 6.8), 2% SDS, 5%
glycerol, 1% 2-mercaptoethanol]. Protein concentrations were deter-
mined with the amido black method (52), and equal amounts of total
protein were loaded for SDS-PAGE. All samples, after separation on an
SDS-polyacrylamide gel, were electroblotted onto nitrocellulose mem-
branes (Schleicher & Schuell, Keene, NH) for immunoblotting with the
appropriate antibody. An ECL protein detection kit (Amersham Bio-
sciences) and a Kodak image station were used for visualization of the
bands.
Presentation of data and statistical analysis
Unless stated otherwise, data are presented as mean  SE for n
independent experiments, and levels of significance for differences be-
tween groups were assessed by Student’s t test for unpaired groups.
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